Elevance brushes off fears of spiking Medicare Advantage costs

–Elevance posted mixed results for the first quarter but reaffirmed its 2025 earnings outlook, solidifying guidance it published early to pacify investors after UnitedHealth posted dismal results last week, leading to a selloff of health insurer stocks.– UnitedHealth’ s results were driven by unexpectedly high medical spending on Medicare Advantage…